Muco-cutaneous leishmaniasis in the New World
Open Access
- 1 November 2011
- journal article
- Published by Informa UK Limited in Virulence
- Vol. 2 (6), 547-552
- https://doi.org/10.4161/viru.2.6.17839
Abstract
Infection by the human protozoan parasite Leishmania can lead, depending primarily on the parasite species, to either cutaneous or mucocutaneous lesions, or fatal generalized visceral infection. In the New World, Leishmania (Viannia) species can cause mucocutaneous leishmaniasis (MCL). Clinical MCL involves a strong hyper-inflammatory response and parasitic dissemination (metastasis) from a primary lesion to distant sites, leading to destructive metastatic secondary lesions especially in the nasopharyngal areas. Recently, we reported that metastasizing, but not non-metastatic strains of Leishmania (Viannia) guyanensis, have high burden of a non-segmented dsRNA virus, Leishmania RNA Virus (LRV). Viral dsRNA is sensed by the host Toll-like Receptor 3 (TLR3) thereby inducing a pro-inflammatory response and exacerbating the disease. The presence of LRV in Leishmania opens new perspectives not only in basic understanding of the intimate relation between the parasite and LRV, but also in understanding the importance of the inflammatory response in MCL patients.Keywords
This publication has 26 references indexed in Scilit:
- Retention and Loss of RNA Interference Pathways in Trypanosomatid ProtozoansPLoS Pathogens, 2010
- Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-α productionBMC Infectious Diseases, 2010
- CXCL10 Production by Human Monocytes in Response to Leishmania braziliensis InfectionInfection and Immunity, 2010
- Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasisParasite Immunology, 2009
- Can interferon-γ and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?Clinical and Experimental Immunology, 2007
- Comparative genomic analysis of three Leishmania species that cause diverse human diseaseNature Genetics, 2007
- Influence ofLeishmania (Viannia)Species on the Response to Antimonial Treatment in Patients with American Tegumentary LeishmaniasisThe Journal of Infectious Diseases, 2007
- Mucosal Leishmaniasis Patients Display an Activated Inflammatory T‐cell Phenotype Associated with a Nonbalanced Monocyte PopulationScandinavian Journal of Immunology, 2005
- Decreased In Situ Expression of Interleukin-10 Receptor Is Correlated with the Exacerbated Inflammatory and Cytotoxic Responses Observed in Mucosal LeishmaniasisInfection and Immunity, 2005
- Recurrent lesions in human Leishmania braziliensis infection—reactivation or reinfection?The Lancet, 1990